Recruiting NA Analgesia

Compares treatment options for Analgesia

Official title Pericapsular Nerve Block Versus Intrathecal Morphine for Analgesia After Primary Hip Arthroplasty

ClinicalTrials.gov ID: NCT06317870

What this study is testing

What it's testing
The aim of this clinical trial is to compare the analgesic effect of pericapsular nerve block (PENG) with intrathecal morphine in patients scheduled for total hip replacement surgery. The main question to be answered is whether the PENG block is equivalent to intrathecal morphine in reducing postoperative pain.
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 and older

You may be able to join if

  • Male and female patients
  • ASA (American Society of Anaesthesiologists) I-III
  • 18 years of age or older
  • Patients scheduled for elective primary hip arthroplasty
  • Able to give written conformed consent autonomously

You likely can't join if

  • Refusal or inability to give consent
  • Allergy to any of: ropivacaine, paracetamol, ibuprofen, ketorolac, morphine, ondansetron or dexamethasone
  • Bleeding diathesis
  • Neurological deficit of the operative side
  • Existing preoperative opioid use
  • Renal insufficiency (GFR\<30ml/min according to the Cockroft-Gault formula)
See the full eligibility criteria
Who can join
  • Male and female patients
  • ASA (American Society of Anaesthesiologists) I-III
  • 18 years of age or older
  • Patients scheduled for elective primary hip arthroplasty
  • Able to give written conformed consent autonomously
What rules you out
  • Refusal or inability to give consent
  • Allergy to any of: ropivacaine, paracetamol, ibuprofen, ketorolac, morphine, ondansetron or dexamethasone
  • Bleeding diathesis
  • Neurological deficit of the operative side
  • Existing preoperative opioid use
  • Renal insufficiency (GFR\<30ml/min according to the Cockroft-Gault formula)
  • Hepatic insufficiency
  • Pregnant or lactating women

The study team makes the final eligibility decision.

Where it's taking place

  • Lausanne, Canton of Vaud, Switzerland

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Lausanne, Canton of Vaud, Switzerland. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.